|
Diagnostic imaging
Chest X-ray CAD available through
Christie Group
 MONTREAL
and DAYTON, Ohio – Riverain Medical announced that the company will be
partnering with Canadian medical imaging distributor Christie Group to
offer SoftView Enhanced Chest Imaging and OnGuard Chest X-ray CAD. The
exclusive agreement will bring Dayton, Ohio based Riverain Medical’s
products to the Canadian market through Christie Group’s established
sales channel.
SoftView Enhanced Chest Imaging increases the clarity of digital chest
X-ray images by suppressing bone and providing a soft tissue image for
more confident image interpretations. This practical enterprise-wide
solution uses existing X-ray equipment, providing a soft tissue image
for digital chest X-rays.
OnGuard Chest X-ray CAD identifies solitary pulmonary nodules on a chest
X-ray, which could represent early-stage lung cancer. With universal
PACS connectivity and seamless integration into the radiologist’s
existing workstation, OnGuard is a quick and easy to use tool in the
fight against lung cancer. A recent study demonstrates that OnGuard can
detect almost 50% of lung cancers that were missed in the initial
interpretation.
“Our technologies turn a century-old medical procedure, the chest X-ray,
into a more precise, versatile solution for detecting medical
conditions,” said Diane Hirakawa, CEO and Chairman of Riverain Medical.
“Riverain Medical is making a difference in the healthcare industry. We
create solutions that are practical, safe and improve the detection of
diseases early, when it really counts.”
“Christie is really proud to partner with Riverain today,” says Andre
Dugas, COO of Christie Group. “This novel bone removal and CAD solution
bolsters and valuably complements our broad radiology product portfolio.
It fits on any PACS, with any radiographic chest image from any source,
providing a global, cost-effective tool for lung disease detection and
evaluation.”
About Riverain Medical
Dayton, Ohio based Riverain Medical is an industry leader and technology
innovator, providing physicians with tools to assist them in image
interpretation. With a focus on early detection, Riverain continues
research and development efforts to advance imaging technologies in new
and innovative applications.
Riverain is dedicated to saving lives by improving the detection and
diagnosis of diseases and other clinical conditions. The company’s
researchers and clinical partnerships are a vital part of this mission.
Cleveland Clinic, Georgetown University Medical Center, University of
Chicago, University Hospitals of Cleveland and Amsterdam Medical Center
collaborate with Riverain to ensure that products are high-quality and
clinically effective technologies.
About Christie Group
Christie Group develops, distributes, integrates and supports
technological products and solutions that improve performance of
Canadian health care institutions in the areas of medical imaging and
healthcare management solutions.
Christie’s professionals across the country help hospitals and clinics
to optimize their imaging rooms and to enhance their performance in
terms of screening, diagnosis, and management. Christie delivers their
customers extensive technical and clinical support for improving
workflows, optimizing use of imaging technology, thereby helping them
delivering the best care possible to the ones that count on them. For
more information:
www.christiegrp.com
Posted Nov.26, 2009
|
